Form 4: Relay Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations

Brian Adams, Chief Legal Officer of Relay Therapeutics, sold 295 shares of common stock on June 27, 2024, to cover income tax withholding obligations upon the vesting of restricted stock units.

Summary

• On June 27, 2024, Brian Adams, the Chief Legal Officer of Relay Therapeutics, sold 295 shares of the company's common stock.
• The sale was executed at a price of $6.26 per share.
• This transaction was to cover income tax withholding obligations related to the vesting of 992 restricted stock units (RSUs) on June 26, 2024.
• Following the transaction, Adams beneficially owns 325,472 shares, which includes 290,328 shares underlying RSUs.
• The sale was conducted in accordance with Relay Therapeutics' policies regarding the vesting of RSUs, and Adams had no discretion over the sale.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (sale of shares to cover tax obligations) by a company insider, which is neither particularly positive nor negative. It's a neutral event in the context of the company's overall performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This particular transaction appears to be routine, covering tax obligations related to RSU vesting, which is a common form of executive compensation.

Key Dates